DataCeutics’ Response to Bipartisan Bill 1234

BIPARTISAN BILL PLANS TO ALLOW A TAX CREDIT FOR 35% OF CONTRACTED RESEARCH EXPENSES

 

Monday, April 10th (Philadelphia, PA) - DataCeutics, a niche CRO with headquarters in the greater Philadelphia area, provides contract research SAS Programming products and services to the pharmaceutical and biotech industry.  “We are encouraged by Congressman Patrick Meehan (R-PA)  along with other fellow Congressmen from North Carolina, regarding their introduction of The Domestic Research Enhancement Act of 2017 (H.R. 1234).  We echo the support and praise along with our industry colleagues for recognizing the CRO sector and the part we play in the US economy”, said Paul Gilbert, President of DataCeutics. 

READ MORE